World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

A PILOT STUDY OF EFFECTIVENESS OF UNANI TREATMENT IN UQR (INFERTILITY)

Qhuddsia Q. N. and Dr. Arshiya Sultana*

ABSTRACT

Introduction: Infertility is a failure of a conception in a couples having regular, unprotected coitus for a year. Alteration in Mizaj al-Rahim, congenital abnormality or biochemical changes in cervical secretion and presence of anti-sperm antibody in the cervix leads to cervical hostility. Therefore the aim of this study was to appraise the usefulness of Unani treatment in infertility due to cervical mucus factor. Materials and Methods: This study was conducted in infertile patients due to cervical mucus factor (n=12) at Govt Nizamia Tibbi hospital, Hyderabad. The inclusion criteria includes infertile married woman aged 18-35 year with normal ovulatory cycles, patent fallopian tubes and normal sperms count of husband. The exclusion criteria were congenital anomalies, tubal blockage, systemic diseases, PCOD, anovulation and obesity. On the basis of Unani Usool-i-Ila’j, Munzij (11 days) and Mushil (3 alternate days) with Tabrid were given in first month of the enrollment. From second month orally Sufuf of Buroode Dandane Feel (2g) and Resha Bargad (2g) with 4g sugar and Majoon Supari Pak 5 g was given twice daily from day 1 to day 10 with vaginal humool (powder of Joazbuwa, Kuzmazij, Phitkari Biryani, and Poste Anar each 2g with Roghan Chameeli 10 g) from day 6 to day 10 was given. The outcome was conception. Results: In the present study, minimum age was 18 years and maximum age was 31 years. Eight patients had primary infertility and four patients had secondary infertility. Out of 12 patients, seven (58.33%) patients conceived. Conclusions: This study shows that aforementioned Unani treatment is useful in Uqr. Hence, further phase II and III randomized controlled trials are recommended.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR